Medley Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 33.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 30.76 Cr
as on 23-10-2024
- Company Age 49 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.40 Cr
as on 23-10-2024
- Satisfied Charges ₹ 254.55 Cr
as on 23-10-2024
- Revenue 3.43%
(FY 2023)
- Profit 96.73%
(FY 2023)
- Ebitda 17.89%
(FY 2023)
- Net Worth 15.51%
(FY 2023)
- Total Assets 11.61%
(FY 2023)
About Medley Pharmaceuticals
The Corporate was formerly known as Medley Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 33.00 Cr and a paid-up capital of Rs 30.76 Cr.
The company currently has active open charges totaling ₹37.40 Cr. The company has closed loans amounting to ₹254.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medley Pharmaceuticals Limited India are Devendra Bhagat as CFO and Ravindra More as Company Secretary. Sahir Khatib, Sarosh Khatib, Saba Ali, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1975PLC018296
- Company No.
018296
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1975
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medley Pharmaceuticals Limited offer?
Medley Pharmaceuticals Limited offers a wide range of products and services, including Pantoprazole Drugs, Pantoprazole Tablets, Arthritic Drugs, Aceclofenac Tablet, Diabetes Medicine, Antacid Drugs, Fungal Diastase Pepsin Syrup, Antiemetic Drugs, Domperidone Tablet, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Medley Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarosh Khatib  | Managing Director | 17-Jul-1987 | Current |
| Devendra Bhagat | CFO | Current | |
| Ravindra More | Company Secretary | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sahir Khatib | Whole-Time Director | 01-Sep-1998 | Current |
| Saba Ali | Director | 24-Feb-2015 | Current |
| Mirasif Ali | Whole-Time Director | 27-Sep-1999 | Current |
| Suhel Khatib | Director | 01-Apr-2010 | Current |
| Mohamed Sheikh | Director | 26-Jul-2024 | Current |
| Sucheta Mudgerikar | Director | 26-Jul-2024 | Current |
Financial Performance of Medley Pharmaceuticals.
Medley Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.43% increase. The company also saw a substantial improvement in profitability, with a 96.73% increase in profit. The company's net worth Soared by an impressive increase of 15.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medley Pharmaceuticals?
In 2023, Medley Pharmaceuticals had a promoter holding of 99.98% and a public holding of 0.02%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sinkhai Healthcare LimitedActive 19 years 9 monthsSarosh Khatib and Ravindra More are mutual person
Sinkhai Leathers Private LimitedActive 36 years 3 monthsSahir Khatib and Sarosh Khatib are mutual person
- Sorbo Monni Chemicals Private LimitedActive 41 years 6 months
Sahir Khatib and Suhel Khatib are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jun 2022 | ₹20.00 Cr | Open |
Others Creation Date: 15 Apr 2021 | ₹1.00 M | Open |
State Bank Of India Creation Date: 31 Mar 1999 | ₹17.30 Cr | Open |
How Many Employees Work at Medley Pharmaceuticals?
Medley Pharmaceuticals has a workforce of 2864 employees as of Oct 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medley Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medley Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
